Inside Precision Medicine April 17, 2024
Scopio Labs, an imaging and analysis focused medtech company based in Israel, have received De Novo FDA clearance for its artificial intelligence (AI)-driven bone marrow aspirate analysis software.
Bone marrow samples are important for diagnosing a range of different blood disorders such as different blood cancers, but standard methods of analyzing these samples are time consuming and rely on the skills, knowledge and in-person presence of trained hematopathologists to ensure accuracy.
Scopio produces two machines, one designed for smaller labs and lower throughput and a higher throughput machine, that are able to image blood and other cells in high detail.
The newly approved full-field bone marrow aspirate application uses AI to analyze thousands of cells in each bone marrow sample...
Today's Sponsors
Today's Sponsor